NATHBIOGEN

Nath Bio-Genes (India) Share PriceNath Bio-Genes (India)

₹140.5
2.15 (1.55%)
As on 29 March, 2023 | 14:51 BSE: 537291 NSE: NATHBIOGEN

Nath Bio-Genes (India) Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Nath Bio-Genes (India)

Start SIP

Nath Bio-Genes (India) Share Price

  • Over 1 Month -2.46%
  • Over 3 Month -11.13%
  • Over 6 Month -11.61%
  • Over 1 Year -37.72%

Nath Bio-Genes (India) Key Statistics

P/E Ratio -3.2
PEG Ratio 0
Market Cap Cr 267
Price to Book Ratio 0.5
EPS 12.5
Dividend 1.4
Relative Strength Index 32.91
Money Flow Index 30.41
MACD Signal -1.78
Average True Range 5.88

Nath Bio-Genes (India) Investment Rating

  • Master Rating:
  • Nath Bio Genes India has an operating revenue of Rs. 283.59 Cr. on a trailing 12-month basis. An annual revenue de-growth of -9% needs improvement, Pre-tax margin of -23% needs improvement, ROE of -12% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 27 which is a POOR score indicating inconsistency in earnings, a RS Rating of 32 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 44 indicates it belongs to a fair industry group of Agricultural Operations and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Nath Bio-Genes (India) Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 252220927
Operating Expenses Qtr Cr 201717548
Operating Profit Qtr Cr 6534-21
Depreciation Qtr Cr 1111
Interest Qtr Cr 3332
Tax Qtr Cr 1003
Net Profit Qtr Cr 1131-116

Nath Bio-Genes (India) Technicals

EMA & SMA

Current Price
₹140.5
2.15 (1.55%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 144.82
  • 50 Day
  • 149.27
  • 100 Day
  • 155.91
  • 200 Day
  • 172.2
  • 20 Day
  • 145.5
  • 50 Day
  • 149.29
  • 100 Day
  • 156.96
  • 200 Day
  • 165.84

Nath Bio-Genes (India) Resistance and Support

PIVOT
₹139.35
Resistance
First Resistance 140.65
Second Resistance 142.95
Third Resistance 144.25
RSI 32.91
MFI 30.41
MACD Single Line -1.78
MACD -2.38
Support
First Resistance 137.06
Second Resistance 135.75
Third Resistance 133.45

Nath Bio-Genes (India) Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 9,141 881,832 96.47
Week 23,158 1,785,466 77.1
1 Month 38,969 2,928,109 75.14
6 Month 38,608 2,442,320 63.26

Nath Bio-Genes (India) Result Highlights

Nath Bio-Genes (India) Synopsis

NSE-Agricultural Operations

Nath Bio-Genes is involved in the business activities of Growing of non-perennial crops. Company’s Total Operating Revenue is Rs. 278.36 Cr. and Equity Capital is Rs. 19.00 Cr. for the Year ended 31/03/2022. Nath Bio-Genes (India) Ltd. is a Public Limited Listed company incorporated on 14/07/1993 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L01110MH1993PLC072842 and registration number is 072842.
Market Cap 267
Sales 284
Shares in Float 1.03
No of funds 13
Yield 1.45
Book Value 0.49
U/D Vol ratio 0.9
LTDebt / Equity
Alpha -0.13
Beta 1.15

Nath Bio-Genes (India)

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 45.6%45.6%41.07%
Mutual Funds 4.62%4.62%4.62%
Foreign Portfolio Investors 0.15%0.01%0.11%
Financial Institutions/ Banks
Individual Investors 30.62%31.61%31.29%
Others 19.01%18.16%22.91%

Nath Bio-Genes (India) Management

Name Designation
Mr. Satish Kagliwal Managing Director
Mr. Madhukar Deshpande Director
Ms. Ashu Jain Director
Mr. Hitesh Purohit Director
Mrs. Jeevanlata Kagliwal Director
Mr. Vadla Nagabhushanam Director
Mrs. Sweta Kagliwal Director

Nath Bio-Genes (India) Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Nath Bio-Genes (India) MF Shareholding

Name Amount(cr)
Aditya Birla Sun Life Pure Value Fund Growth 3798

Nath Bio-Genes (India) FAQs

What is Share Price of Nath Bio-Genes (India) ?

Nath Bio-Genes (India) share price is ₹140 As on 29 March, 2023 | 14:37

What is the Market Cap of Nath Bio-Genes (India) ?

The Market Cap of Nath Bio-Genes (India) is ₹267 Cr As on 29 March, 2023 | 14:37

What is the P/E ratio of Nath Bio-Genes (India) ?

The P/E ratio of Nath Bio-Genes (India) is -3.2 As on 29 March, 2023 | 14:37

What is the PB ratio of Nath Bio-Genes (India) ?

The PB ratio of Nath Bio-Genes (India) is 0.5 As on 29 March, 2023 | 14:37

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number